Fulcrum Therapeutics Announces Positive Initial Results from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting
December 06, 2025 17:30 ET  | Source: Fulcrum Therapeutics, Inc. ― Clear…
HKUST Commences Preparations for New Medical School
Inaugural Cohort in 2028, Cultivating Clinically Excellent and Technology-Savvy Doctors of the Future…
GBS Malta Celebrates Landmark Inaugural Graduation
ST JULIAN'S, Malta, Nov. 19, 2025 /PRNewswire/ -- GBS Malta, part of…
Comprehensive Healthcare Takes Next Step Toward Expanding Access to Behavioral Healthcare in Central Washington
YAKIMA, Wash., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Comprehensive Healthcare today announced…
GT Biopharma Provides Enrollment Update on GTB-3650 Phase 1 Trial in Patients with Relapsed or Refractory (r/r) CD33 Expressing Hematologic Malignancies
The formal safety review of Cohort 3 (5ug/kg/day) has been successfully completed…
Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer
Media Release COPENHAGEN, Denmark; October 18, 2025 Updated data from the Phase…
Ten athlete ambassadors engaged in preventing competition manipulation announced
10 September 2025 – Ten athletes from every continent and 10 different…
Mohamed bin Zayed University of Artificial Intelligence begins new academic year with largest-ever cohort of 400+ students
ABU DHABI,UAE, Aug. 16, 2025 /PRNewswire/ -- Mohamed bin Zayed University of…
Alamar Biosciences and the German Center for Neurodegenerative Diseases (DZNE) partner for Landmark Proteomic Profiling study in the Rhineland Study Cohort
NULISAseqâ„¢ CNS Disease Panel 120 and Inflammation Panel 250 to Power Biomarker…
SPJIMR’s PGDM Class of 2027 celebrates leadership, diversity, and purpose
New cohort embarks on a transformative journey in management and leadership MUMBAI,…